Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 22, Issue 9, Pages 1174-1183
Publisher
SAGE Publications
Online
2015-11-13
DOI
10.1177/1352458515615225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI
- (2014) Mike P. Wattjes et al. CURRENT OPINION IN NEUROLOGY
- Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?
- (2014) Mike P. Wattjes et al. JOURNAL OF NEUROLOGY
- MRI pattern in asymptomatic natalizumab-associated PML
- (2014) Mike P Wattjes et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
- (2014) H. Butzkueven et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Outcome and survival of asymptomatic PML in natalizumab-treated MS patients
- (2014) Tuan Dong-Si et al. Annals of Clinical and Translational Neurology
- Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
- (2013) P. S. Rommer et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort
- (2013) O. Outteryck et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinical effects of natalizumab on multiple sclerosis appear early in treatment course
- (2013) Ludwig Kappos et al. JOURNAL OF NEUROLOGY
- Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
- (2013) Mike P Wattjes et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab
- (2013) Morten Blinkenberg et al. Multiple Sclerosis Journal
- The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy
- (2013) Mike P Wattjes et al. Multiple Sclerosis Journal
- PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section
- (2013) J. R. Berger et al. NEUROLOGY
- Presymptomatic Diagnosis with MRI and Adequate Treatment Ameliorate the Outcome after Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2013) Hans Lindå et al. Frontiers in Neurology
- Reduced Diffusion in a Subset of Acute MS Lesions: A Serial Multiparametric MRI Study
- (2012) P. Eisele et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy
- (2012) Tarek A. Yousry et al. ANNALS OF NEUROLOGY
- Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab
- (2012) Eavan M. Mc Govern et al. JOURNAL OF NEUROLOGY
- Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
- (2012) Per Soelberg Sørensen et al. Multiple Sclerosis Journal
- The earlier, the smaller, the better for natalizumab-associated PML: In MRI vigilance veritas?
- (2012) R. Phan-Ba et al. NEUROLOGY
- Natalizumab
- (2012) Richard Rudick et al. JAMA Neurology
- Risks and benefits of multiple sclerosis therapies: need for continual assessment?
- (2011) Bernd C Kieseier et al. CURRENT OPINION IN NEUROLOGY
- Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis
- (2011) A. Melin et al. JOURNAL OF NEUROLOGY
- MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy: Figure 1
- (2011) Rémy Phan-Ba et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
- (2011) Ludwig Kappos et al. LANCET NEUROLOGY
- MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
- (2011) Frederik Barkhof et al. Nature Reviews Neurology
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
- (2010) Chen S Tan et al. LANCET NEUROLOGY
- Improved Detection of Active Multiple Sclerosis Lesions: 3D Subtraction Imaging
- (2010) Bastiaan Moraal et al. RADIOLOGY
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search